Literature DB >> 1471628

Dosage standardization for filgrastim.

K W Burke.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1471628

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN： 0002-9289


× No keyword cloud information.
  2 in total

Review 1.  Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.

Authors:  K L Goa; H M Bryson
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981

2.  Filgrastim. A reappraisal of pharmacoeconomic considerations in the prophylaxis and treatment of chemotherapy-induced neutropenia.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.